ONCY:NASDAQ
Oncolytics Biotech Inc
$0.54
arrow_downward
-0.77%(-0.0042) 1D
Oct 9, 10:05:19 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ONCY...
Open
$0.55
High
$0.55
Low
$0.52
Mkt. cap
71.41M
Avg. vol.
1.05M
Volume
153.23K
52-wk high
$1.32
52-wk low
$0.52
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
Open
$0.55
High
$0.55
Low
$0.52
Mkt. cap
71.41M
Avg. vol.
1.05M
Volume
153.23K
52-wk high
$1.32
52-wk low
$0.52
Beta
1.15
Shares outstanding
127.51M
No. of employees
29
News stories
From web sources and news partners
marketscreener.com
·
5 minutes ago
Wall St climbs as oil slips; SpaceX spectrum deal weighs on telecoms
Investor's Business Daily
·
16 minutes ago
Stock Market: Nasdaq, S&P 500 Hit New Highs Despite OpenAI Fears; Small Caps Slump: Weekly Review
24/7 Wall St.
·
46 minutes ago
Stock Market Today: Tech Leads Stocks Toward a Higher Open as Treasury Yields Ease
Profile
Oncolytics Biotech Inc. is a biotech company headquartered in San Diego, California, that is developing an intravenously delivered immuno-oncolytic virus called pelareorep for the treatment of solid tumors and hematological malignancies. Pelareorep is a non-pathogenic, proprietary isolate of the unmodified reovirus that induces selective tumor lysis and promotes an inflamed tumor phenotype through innate and adaptive immune responses. Wikipedia
About Oncolytics Biotech Inc
CEO-
Employees29
Founded1998
HeadquartersCalgary, Alberta, Canada
SectorBiotechnology
Websiteoncolyticsbiotech.com